OB/GYN: FDA approves generic abortion drug

OB/GYN: FDA approves generic abortion drug

Published on: 10/11/2025

The FDA just approved a generic version of the abortion pill mifepristone, marking a critical moment for women’s healthcare and access to reproductive choice. Seeking commentary, including: (1) Why is this pill controversial? (2) How might its approval help improve access to reproductive healthcare for women? (3) When might it become available? (4) Will it face the same restrictions as the brand-name drug? (5) What does this decision mean for the future of women’s health and destigmatizing care?

Published on: 10/11/2025

OB/GYN: FDA approves generic abortion drug

Published on: 10/11/2025

A recent study found that those using azelastine nasal spray three times daily for 56 days had a 69% lower chance of contracting COVID-19. The spray also reduced the risk of rhinovirus infections, a common cold virus, by about 71%. Seeking commentary, including: (1) What are the side effects of using this nasal spray? (2) Are there any risks with prolonged use of this medication? (3) Is there anyone who should be cautious about trying this? (4) Can this spray replace getting a COVID vaccination? (5) What should people do if they want to give it a try?

Published on: 10/7/2025

Physicians: Azelastine nasal spray lowers chance of contracting COVID-19

Published on: 10/7/2025

20 Pitching Tips to Win Media Coverage in 2025

Real Pitches That Landed Coverage on WSJ, Forbes & More…

Top 12 AI Tools For Better Media Pitching

How to Pitch a Journo Request? (A Complete Beginner's Guide)